135 related articles for article (PubMed ID: 32971099)
1. Inhibition of platelet aggregation and blood coagulation by a P-III class metalloproteinase purified from Naja atra venom.
Sun QY; Wang CE; Li YN; Bao J
Toxicon; 2020 Nov; 187():223-231. PubMed ID: 32971099
[TBL] [Abstract][Full Text] [Related]
2. Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system.
Zhong XJ; Wang CE; Li YN; Zhang QY; Sun QY
Heliyon; 2024 May; 10(10):e30969. PubMed ID: 38813202
[TBL] [Abstract][Full Text] [Related]
3. Cobra venom P-III class metalloproteinase atrase A induces inflammatory response and cell apoptosis in endothelial cells via its metalloproteinase domain.
Wei Y; Lu QY; Zhong XJ; Guo L; Zeng FY; Sun QY
Toxicon; 2023 Aug; 232():107210. PubMed ID: 37393957
[TBL] [Abstract][Full Text] [Related]
4. Atrase B, a novel metalloprotease with anti-complement and anti-coagulant activity, significantly delays discordant cardiac xenograft rejection.
Fu C; Shi L; Huang X; Feng H; Tan X; Chen S; Zhu L; Sun Q; Chen G
Xenotransplantation; 2020 Sep; 27(5):e12616. PubMed ID: 32529740
[TBL] [Abstract][Full Text] [Related]
5. Purification, cloning and characterization of a metalloproteinase from Naja atra venom.
Sun QY; Bao J
Toxicon; 2010 Dec; 56(8):1459-69. PubMed ID: 20837040
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the anticoagulants from Taiwan cobra (Naja naja atra) snake venom.
Teng CM; Kuo YP; Lee LG; Ouyang CH
Toxicon; 1987; 25(2):201-10. PubMed ID: 3576637
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic interference of Indian king cobra (Ophiophagus hannah) Venom. Comparison with three other snake venoms of the subcontinent.
Gowtham YJ; Kumar MS; Girish KS; Kemparaju K
Biochemistry (Mosc); 2012 Jun; 77(6):639-47. PubMed ID: 22817464
[TBL] [Abstract][Full Text] [Related]
8. Differential action of medically important Indian BIG FOUR snake venoms on rodent blood coagulation.
Hiremath V; Nanjaraj Urs AN; Joshi V; Suvilesh KN; Savitha MN; Urs Amog P; Rudresha GV; Yariswamy M; Vishwanath BS
Toxicon; 2016 Feb; 110():19-26. PubMed ID: 26592458
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human platelet aggregation by L-amino acid oxidase purified from Naja naja kaouthia venom.
Sakurai Y; Takatsuka H; Yoshioka A; Matsui T; Suzuki M; Titani K; Fujimura Y
Toxicon; 2001 Dec; 39(12):1827-33. PubMed ID: 11600144
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxin from Naja naja atra snake venom: a potentiator of platelet aggregation.
Teng CM; Jy W; Ouyang C
Toxicon; 1984; 22(3):463-70. PubMed ID: 6474495
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant mechanism and platelet deaggregation property of a non-cytotoxic, acidic phospholipase A2 purified from Indian cobra (Naja naja) venom: inhibition of anticoagulant activity by low molecular weight heparin.
Dutta S; Gogoi D; Mukherjee AK
Biochimie; 2015 Mar; 110():93-106. PubMed ID: 25576831
[TBL] [Abstract][Full Text] [Related]
12. Differential action of proteases from Trimeresurus malabaricus, Naja naja and Daboia russellii venoms on hemostasis.
Gowda CD; Nataraju A; Rajesh R; Dhananjaya BL; Sharath BK; Vishwanath BS
Comp Biochem Physiol C Toxicol Pharmacol; 2006 Jul; 143(3):295-302. PubMed ID: 16627005
[TBL] [Abstract][Full Text] [Related]
13. In vitro procoagulant and anticoagulant properties of Naja naja naja venom.
Sundell IB; Rånby M; Zuzel M; Robinson KA; Theakston RD
Toxicon; 2003 Sep; 42(3):239-47. PubMed ID: 14559074
[TBL] [Abstract][Full Text] [Related]
14. Systemic effects induced by the venom of the snake Bothrops caribbaeus in a murine model.
Herrera C; Rucavado A; Warrell DA; Gutiérrez JM
Toxicon; 2013 Mar; 63():19-31. PubMed ID: 23159397
[TBL] [Abstract][Full Text] [Related]
15. Thrombolytic protein from cobra venom with anti-adhesive properties.
Chanda C; Sarkar A; Chakrabarty D
Arch Biochem Biophys; 2016 Jan; 590():20-26. PubMed ID: 26558696
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation.
Serrano SMT; Wang D; Shannon JD; Pinto AFM; Polanowska-Grabowska RK; Fox JW
FEBS J; 2007 Jul; 274(14):3611-3621. PubMed ID: 17578514
[TBL] [Abstract][Full Text] [Related]
17. Novel Catalytically-Inactive PII Metalloproteinases from a Viperid Snake Venom with Substitutions in the Canonical Zinc-Binding Motif.
Camacho E; Sanz L; Escalante T; Pérez A; Villalta F; Lomonte B; Neves-Ferreira AG; Feoli A; Calvete JJ; Gutiérrez JM; Rucavado A
Toxins (Basel); 2016 Oct; 8(10):. PubMed ID: 27754342
[TBL] [Abstract][Full Text] [Related]
18. Snake venoms and the hemostatic system.
Markland FS
Toxicon; 1998 Dec; 36(12):1749-800. PubMed ID: 9839663
[TBL] [Abstract][Full Text] [Related]
19. Complete amino acid sequence of kaouthiagin, a novel cobra venom metalloproteinase with two disintegrin-like sequences.
Ito M; Hamako J; Sakurai Y; Matsumoto M; Fujimura Y; Suzuki M; Hashimoto K; Titani K; Matsui T
Biochemistry; 2001 Apr; 40(14):4503-11. PubMed ID: 11284707
[TBL] [Abstract][Full Text] [Related]
20. Isolation and cloning of a metalloproteinase from king cobra snake venom.
Guo XX; Zeng L; Lee WH; Zhang Y; Jin Y
Toxicon; 2007 Jun; 49(7):954-65. PubMed ID: 17337026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
